Crossmark Global Holdings’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $208K | Buy |
13,834
+439
| +3% | +$6.6K | ﹤0.01% | 1259 |
|
|
2025
Q1 | $177K | Buy |
13,395
+635
| +5% | +$8.38K | ﹤0.01% | 1278 |
|
|
2024
Q4 | $201K | Sell |
12,760
-2,135
| -14% | -$33.6K | ﹤0.01% | 1211 |
|
|
2024
Q3 | $237K | Sell |
14,895
-3,030
| -17% | -$48.2K | ﹤0.01% | 1178 |
|
|
2024
Q2 | $273K | Sell |
17,925
-2,710
| -13% | -$41.3K | 0.01% | 1104 |
|
|
2024
Q1 | $303K | Buy |
20,635
+170
| +0.8% | +$2.5K | 0.01% | 1091 |
|
|
2023
Q4 | $285K | Buy |
20,465
+135
| +0.7% | +$1.88K | 0.01% | 1088 |
|
|
2023
Q3 | $271K | Buy |
20,330
+365
| +2% | +$4.87K | 0.01% | 1068 |
|
|
2023
Q2 | $275K | Sell |
19,965
-160
| -0.8% | -$2.2K | 0.01% | 1111 |
|
|
2023
Q1 | $229K | Buy |
+20,125
| New | +$229K | 0.01% | 1167 |
|
|
2022
Q4 | – | Sell |
-21,115
| Closed | -$221K | – | 1273 |
|
|
2022
Q3 | $221K | Sell |
21,115
-4,635
| -18% | -$48.5K | 0.01% | 1131 |
|
|
2022
Q2 | $285K | Buy |
+25,750
| New | +$285K | 0.01% | 1052 |
|
|
2021
Q4 | – | Sell |
-60,650
| Closed | -$790K | – | 1450 |
|
|
2021
Q3 | $790K | Sell |
60,650
-7,650
| -11% | -$99.6K | 0.02% | 698 |
|
|
2021
Q2 | $1M | Buy |
68,300
+2,550
| +4% | +$37.5K | 0.02% | 611 |
|
|
2021
Q1 | $807K | Buy |
65,750
+2,850
| +5% | +$35K | 0.02% | 676 |
|
|
2020
Q4 | $897K | Buy |
62,900
+4,400
| +8% | +$62.7K | 0.02% | 600 |
|
|
2020
Q3 | $814K | Sell |
58,500
-13,700
| -19% | -$191K | 0.02% | 599 |
|
|
2020
Q2 | $765K | Buy |
+72,200
| New | +$765K | 0.02% | 617 |
|